scholarly article | Q13442814 |
P2093 | author name string | Wei Xue | |
Liang Dong | |||
Guoliang Yang | |||
Yiran Huang | |||
Haige Chen | |||
Ruiyun Zhang | |||
Juanjie Bo | |||
Lianhua Zhang | |||
P2860 | cites work | Sequence investigation of the major gastrointestinal tumor-associated antigen gene family, GA733 | Q24629156 |
Cancer as a complex developmental disorder--nineteenth Cornelius P. Rhoads Memorial Award Lecture | Q48379952 | ||
Chemopreventive activity of systemically administered curcumin on oral cancer in the 4-nitroquinoline 1-oxide model. | Q53226427 | ||
EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. | Q54391399 | ||
TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity | Q58217966 | ||
Bladder cancer | Q84058686 | ||
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015 | Q27468570 | ||
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
Bladder Cancer Treatment (PDQ®): Patient Version | Q28075569 | ||
Trop-2 promotes prostate cancer metastasis by modulating β(1) integrin functions. | Q30539832 | ||
Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma | Q31114927 | ||
Clinical significance of TROP2 expression in colorectal cancer | Q33243832 | ||
Potential new urinary markers in the early detection of bladder cancer | Q33657098 | ||
Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways | Q33909333 | ||
Therapeutic applications of curcumin for patients with pancreatic cancer | Q33948351 | ||
Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway. | Q34158118 | ||
Curcumin promotes KLF5 proteasome degradation through downregulating YAP/TAZ in bladder cancer cells. | Q34358867 | ||
Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases | Q34594807 | ||
High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody | Q35013603 | ||
Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody | Q35083850 | ||
Human trophoblast cell-surface antigens defined by monoclonal antibodies | Q35467267 | ||
High expression of TROP2 correlates with poor prognosis in pancreatic cancer. | Q36944033 | ||
Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins | Q37163664 | ||
Curcumin inhibits cell growth and invasion and induces apoptosis through down-regulation of Skp2 in pancreatic cancer cells | Q37298290 | ||
Trop2: a possible therapeutic target for late stage epithelial carcinomas | Q37580462 | ||
Antitumor activity of curcumin is involved in down-regulation of YAP/TAZ expression in pancreatic cancer cells | Q37694750 | ||
Hitting the golden TORget: curcumin's effects on mTOR signaling | Q38070194 | ||
Molecular mechanisms of curcumin action: signal transduction | Q38072888 | ||
Trop2: from development to disease | Q38293559 | ||
Antitumor effects of curcumin in human bladder cancer in vitro | Q38660081 | ||
Curcumin inhibits bladder cancer progression via regulation of β-catenin expression | Q38697407 | ||
Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway | Q38853976 | ||
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. | Q38876950 | ||
Curcumin as a MicroRNA Regulator in Cancer: A Review | Q38908322 | ||
Upregulation of Trop-2 quantitatively stimulates human cancer growth | Q39393545 | ||
Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NF-kappa B signaling pathways | Q39468048 | ||
Curcumin potentiates the antitumor effects of Bacillus Calmette-Guerin against bladder cancer through the downregulation of NF-kappaB and upregulation of TRAIL receptors | Q39776526 | ||
Gene expression patterns distinguish breast carcinomas from normal breast tissues: the Malaysian context | Q39907197 | ||
TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT. | Q41470890 | ||
Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers | Q42816764 | ||
Protective effects of curcumin supplementation on intestinal ischemia reperfusion injury | Q43715945 | ||
TROP2 expression and its correlation with tumor proliferation and angiogenesis in human gliomas | Q45776265 | ||
Curcumin synergizes with 5-fluorouracil by impairing AMPK/ULK1-dependent autophagy, AKT activity and enhancing apoptosis in colon cancer cells with tumor growth inhibition in xenograft mice | Q47094204 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P921 | main subject | curcumin | Q312266 |
P577 | publication date | 2018-05-30 | |
P1433 | published in | International Journal of Oncology | Q6051527 |
P1476 | title | Curcumin inhibits cell proliferation and motility via suppression of TROP2 in bladder cancer cells. |
Q91813324 | ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer |
Q64062168 | Growth and Proliferation of Renal Cell Carcinoma Cells Is Blocked by Low Curcumin Concentrations Combined with Visible Light Irradiation |
Q64083324 | Targeting Trop-2 in solid tumors: future prospects |
Q91639454 | The roles of curcumin in regulating the tumor immunosuppressive microenvironment |
Q90067384 | [Curcumin suppresses invasiveness and migration of human glioma cells in vitro by inhibiting HDGF/β-catenin complex] |
Search more.